Dr. Michael Mina is an assistant professor in the Department of Epidemiology at the Harvard T. H. Chan School of Public Health. He's also group member with the Center for Communicable Disease Dynamics (CCDD). ^[1]

Dr. Michael Mina spent all his time in school.

He attended Emory University, where he earned his MD and PhD degrees with doctoral work split between CDC, St. Jude Children's Research Hospital, the Respiratory and Meningeal Pathogens Research Unit in Johannesburg, South Africa and the Emory Vaccine Center.

He went on to finish his post-doctoral work at Princeton University in Ecology and Evolutionary Biology with Prof. Bryan Grenfell and at Harvard Medical School in the Department of Genetics with Prof. Stephen Elledge. He completed residency training in clinical pathology at Brigham and Women's Hospital / Harvard Medical School.

Aside from being an assistant professor in the Department of Epidemiology at the Harvard T. H. Chan School of Public Health and a team member at the Center for Communicable Disease Dynamics (CCDD), Mina is also Assistant Professor in Immunology and Infectious disease at HSPH and Associate Medical Director in Clinical Microbiology in the Department of Pathology at Brigham and Women's Hospital, Harvard Medical School.

He appeared on WBUR's Morning Edition on April 10th 2020 to speak about the COVID-19 pandemic.

He touched on the lack of supplies, especially plastic swabs, that are keeping test from being distributed.

He also spoke about the prospect of serological testing, but acknowledged that would take at least a month to become widespread.

He also talked about the difficulties of crafting a vaccine: ^{[2][3] [4][5][6]}